首页 | 本学科首页   官方微博 | 高级检索  
     

应用伊曲康唑预防化疗后继发真菌感染的疗效
摘    要:

关 键 词:恶性血液病 化学治疗 真菌感染 伊曲康唑

A controlled clinical trial of itraconazole for prevention of fungal infections secondary to chemotherapy.
Chun-Yan Wang,Bing-Yi Wu,Kun-Yuan Guo. A controlled clinical trial of itraconazole for prevention of fungal infections secondary to chemotherapy.[J]. Journal of First Military Medical University, 2003, 23(4): 389-390
Authors:Chun-Yan Wang  Bing-Yi Wu  Kun-Yuan Guo
Affiliation:Department of Hematology, Zhujiang Hospital, First Military Medical University, Guangzhou 510282, China. yanchunwa@yahoo.com.cn
Abstract:To study the preventive effect of itraconazole against fungal infections following chemotherapy in tumor patients, we conducted a double-blind randomized clinical trial in 114 tumor patients receiving chemotherapy, who were divided into itraconazole treatment group (n=52) and control group (n=62) and the incidences of fungal infections after chemotherapy were recorded. In comparison with the control group, itraconazole treatment group exhibited a significant decrease in fungal infection episodes (12.8% vs 3.8%), illustrating the efficacy of itraconazole treatment as a preventive measure against fungal infections secondary to chemotherapy.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号